Atlas Trials

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Clinical trial NCT05636176 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05636176
Sponsor
Novo Nordisk A/S
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Heart Failure
Start date
2023-05-08
Primary completion
2027-07-02
Enrollment
4899

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.